Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Liver transplantation1521 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06841 | 32727662 | Gastroenterol Hepatol | COVID-19 and liver disease: An update. | 2020 | Details |
| A06864 | 32718097 | Int J Mol Sci | Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases? | 2020 | Details |
| A06926 | 32695968 | JHEP Rep | New frontiers in liver resection for hepatocellular carcinoma. | 2020 | Details |
| A06961 | 32685936 | Explor Med | Nonalcoholic fatty liver disease and portal hypertension. | 2020 | Details |
| A06993 | 32668632 | Int J Mol Sci | Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone? | 2020 | Details |
| A07018 | 32655232 | J Clin Exp Hepatol | Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology. | 2019 | Details |
| A07021 | 32654868 | J Formos Med Assoc | Non-alcoholic fatty liver disease: A review with clinical and pathological correlation. | 2020 | Details |
| A07070 | 32632389 | Transl Gastroenterol Hepatol | Acute-on-chronic liver failure in liver transplant candidates with non-alcoholic steatohepatitis. | 2020 | Details |
| A07071 | 32632387 | Transl Gastroenterol Hepatol | Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation. | 2020 | Details |
| A07087 | 32627871 | J Gastroenterol Hepatol | Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. | 2020 | Details |
| A07130 | 32608555 | Microsc Res Tech | Accurate assessment of nonalcoholic fatty liver disease lesions in liver allograft biopsies by a smartphone platform: A proof of concept. | 2020 | Details |
| A07200 | 32585136 | Lancet Gastroenterol Hepatol | Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. | 2020 | Details |
| A07257 | 32564624 | Ann Saudi Med | Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation. | 2020 | Details |
| A07299 | 32550751 | World J Gastroenterol | Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management. | 2020 | Details |
| A07341 | 32531342 | Clin Gastroenterol Hepatol | Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States. | 2020 | Details |
| A07342 | 32531295 | Metabolism | Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease. | 2020 | Details |
| A07347 | 32529712 | Clin Physiol Funct Imaging | FDG PET/CT of the non-malignant liver in an increasingly obese world population. | 2020 | Details |
| A07383 | 32518675 | Clin Diabetes Endocrinol | Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand? | 2020 | Details |
| A07388 | 32518095 | CMAJ Open | Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study. | 2020 | Details |
| A07478 | 32479709 | Transpl Infect Dis | Isolated pulmonary fusariosis caused by Neocosmospora pseudensiformis in a liver transplant recipient: A case report and review of the literature. | 2020 | Details |
| A07485 | 32476788 | World J Gastroenterol | Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. | 2020 | Details |
| A07495 | 32475129 | Am J Physiol Gastrointest Liver Physiol | Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease. | 2020 | Details |
| A07549 | 32446022 | Semin Arthritis Rheum | Safety of TNF inhibitors in rheumatic disease in case of NAFLD and cirrhosis. | 2020 | Details |
| A07577 | 32437795 | Life Sci | TLR4 knockout upregulates the expression of Mfn2 and PGC-1α in a high-fat diet and ischemia-reperfusion mice model of liver injury. | 2020 | Details |
| A07586 | 32434740 | Transplant Proc | The Utility of Assessing Liver Allograft Fibrosis and Steatosis Post-Liver Transplantation Using Transient Elastography With Controlled Attenuation Parameter. | 2020 | Details |
| A07591 | 32432142 | World J Clin Cases | Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literature. | 2020 | Details |
| A07610 | 32423665 | Nutr Metab Cardiovasc Dis | Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy. | 2020 | Details |
| A07630 | 32414722 | Clin Med (Lond) | Decompensated cirrhosis is the commonest presentation for NAFLD patients undergoing liver transplant assessment. | 2020 | Details |
| A07656 | 32407331 | PLoS One | A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction. | 2020 | Details |
| A07668 | 32402090 | Aliment Pharmacol Ther | Review article: COVID-19 and liver disease-what we know on 1st May 2020. | 2020 | Details |
| A07670 | 32401092 | Infect Dis (Lond) | Changing indications for liver transplant: slow decline of hepatitis viruses in Italy. | 2020 | Details |
| A07687 | 32390698 | World J Gastroenterol | Macrophages in metabolic associated fatty liver disease. | 2020 | Details |
| A07693 | 32389886 | Clin Gastroenterol Hepatol | Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis. | 2020 | Details |
| A07787 | 32354880 | In Vivo | Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis. | 2021 | Details |
| A07824 | 32344052 | J Hepatol | Liver-related mortality is similar among men and women with cirrhosis. | 2020 | Details |
| A07871 | 32328797 | J Gastroenterol | Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system. | 2020 | Details |
| A07884 | 32323349 | Aliment Pharmacol Ther | The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis. | 2020 | Details |
| A07900 | 32317584 | Eur J Gastroenterol Hepatol | De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: prevalence and predictive factors. | 2021 | Details |
| A07914 | 32312689 | Best Pract Res Clin Obstet Gynaecol | Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease. | 2020 | Details |
| A07928 | 32306654 | Zhonghua Gan Zang Bing Za Zhi | [Diagnosis and treatment strategies for fatty liver when obesity coexists with alcohol consumption]. | 2020 | Details |
| A07989 | 32289115 | JHEP Rep | Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. | 2020 | Details |
| A07990 | 32287173 | Am J Case Rep | Hepatic Artery Thrombosis and Takotsubo Syndrome After Liver Transplantation - Which Came First? | 2020 | Details |
| A07994 | 32285340 | Adv Ther | Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review. | 2020 | Details |
| A08004 | 32282030 | Br Med Bull | Obeticholic acid-a new therapy in PBC and NASH. | 2020 | Details |
| A08028 | 32277591 | Am J Transplant | Fatal outcome in a liver transplant recipient with COVID-19. | 2020 | Details |
| A08034 | 32274348 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations. | 2019 | Details |
| A08042 | 32272251 | Clin Gastroenterol Hepatol | Diagnostic Performance of Vibration-Controlled Transient Elastography in Liver Transplant Recipients. | 2020 | Details |
| A08070 | 32258522 | Transl Gastroenterol Hepatol | Peri-transplant renal dysfunction in patients with non-alcoholic steatohepatitis undergoing liver transplantation. | 2020 | Details |
| A08079 | 32256016 | World J Gastroenterol | Importance of genetic polymorphisms in liver transplantation outcomes. | 2020 | Details |
| A08118 | 32240717 | J Hepatol | Changes in frailty are associated with waitlist mortality in patients with cirrhosis. | 2020 | Details |
| A08184 | 32216182 | Rev Med Suisse | [New trends in non-alcoholic fatty liver diseases (NAFLD)]. | 2020 | Details |
| A08240 | 32190778 | Transl Gastroenterol Hepatol | Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates . | 2020 | Details |
| A08248 | 32189102 | Dig Dis Sci | Progression to Cirrhosis Leads to Improvement in Atherogenic Milieu. | 2020 | Details |
| A08261 | 32184169 | Gene | Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2020 | Details |
| A08265 | 32181573 | Liver Int | Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives. | 2020 | Details |
| A08272 | 32175386 | Ann Transl Med | Scientometric analysis of mTOR signaling pathway in liver disease. | 2020 | Details |
| A08333 | 32150036 | Transplantation | Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C. | 2020 | Details |
| A08517 | 32077612 | Liver Int | Approach to the patient with chronic hepatitis B and decompensated cirrhosis. | 2020 | Details |
| A08523 | 32075238 | Nutrients | Impact of the Co-Administration of N-3 Fatty Acids and Olive Oil Components in Preclinical Nonalcoholic Fatty Liver Disease Models: A Mechanistic View. | 2020 | Details |
| A08527 | 32073688 | Clin Transplant | Liver transplant waitlist outcomes in alcoholic hepatitis compared with other liver diseases: An analysis of UNOS registry. | 2020 | Details |
| A08529 | 32071558 | Int J Biol Sci | Mesenchymal stromal cells promote liver regeneration through regulation of immune cells. | 2020 | Details |
| A08557 | 32061907 | Metabolism | Established and emerging factors affecting the progression of nonalcoholic fatty liver disease. | 2020 | Details |
| A08561 | 32061595 | Gastroenterology | Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. | 2020 | Details |
| A08589 | 32048317 | J Gastroenterol Hepatol | Nonalcoholic fatty liver disease burden: Australia, 2019-2030. | 2020 | Details |
| A08652 | 32033758 | Gastroenterol Clin North Am | Pharmacologic Treatment Strategies for Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08679 | 32025164 | J Clin Exp Hepatol | Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965. | 2019 | Details |
| A08701 | 32017891 | Am J Med | Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know? | 2020 | Details |
| A08735 | 32006558 | Metabolism | Complications, morbidity and mortality of nonalcoholic fatty liver disease. | 2020 | Details |
| A08736 | 32006545 | Gastroenterology | AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review. | 2020 | Details |
| A08743 | 32003679 | Curr Pharm Des | Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State? | 2020 | Details |
| A08744 | 32003662 | Curr Pharm Des | Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD). | 2020 | Details |
| A08875 | 31954491 | J Hepatol | Advances in resection and transplantation for hepatocellular carcinoma. | 2020 | Details |
| A08934 | 31931541 | Z Gastroenterol | A young patient with type 2 diabetes associated non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma. | 2020 | Details |
| A09031 | 31898413 | Am J Transplant | OPTN/SRTR 2018 Annual Data Report: Liver. | 2020 | Details |
| A09049 | 31889539 | Transplant Proc | Minimally Invasive Sleeve Gastrectomy as a Surgical Treatment for Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. | 2019 | Details |
| A09090 | 31880680 | J Pediatr Gastroenterol Nutr | Early Obesity: Risk Factor for Fatty Liver Disease. | 2020 | Details |
| A09125 | 31866269 | J Visc Surg | Metabolic syndrome and hepatic surgery. | 2019 | Details |
| A09146 | 31858523 | Histol Histopathol | Hepatocellular carcinoma in non-alcoholic fatty liver disease (NAFLD) - pathological evidence for a predominance of steatohepatitic inflammatory non-proliferative subtype. | 2019 | Details |
| A09175 | 31847612 | Expert Opin Investig Drugs | The molecular basis for current targets of NASH therapies. | 2019 | Details |
| A09207 | 31835505 | Nutrients | Weight Gain and De Novo Metabolic Disorders after Liver Transplantation. | 2019 | Details |
| A09416 | 31757728 | Presse Med | [Epidemiology of non-alcoholic steatohepatitis. Extent/burden of the problem and its impact on public health]. | 2019 | Details |
| A09441 | 31749300 | Liver Int | Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver disease. | 2019 | Details |
| A09485 | 31726747 | Diseases | Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far? | 2019 | Details |
| A09537 | 31703268 | Int J Environ Res Public Health | Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives. | 2019 | Details |
| A09538 | 31703079 | PLoS One | Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation. | 2019 | Details |
| A09556 | 31695252 | J Clin Exp Hepatol | Preventive Strategies for Nonalcoholic Fatty Liver Disease After Liver Transplantation. | 2019 | Details |
| A09639 | 31665561 | Liver Transpl | Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox. | 2020 | Details |
| A09669 | 31652761 | Nutrients | Obesity in the Liver Transplant Setting. | 2019 | Details |
| A09690 | 31646583 | Eur Rev Med Pharmacol Sci | Key molecular pathways in the progression of non-alcoholic steatohepatitis. | 2019 | Details |
| A09704 | 31638518 | Am Surg | One Hundred Fifty Liver Transplants at a New Program in the Modern Era: The University of Mississippi Experience. | 2019 | Details |
| A09713 | 31635470 | Vnitr Lek | Liver transplantation - changes in indications over last decade. | 2019 | Details |
| A09737 | 31630912 | Surg Oncol | Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium. | 2019 | Details |
| A09763 | 31620616 | Yeungnam Univ J Med | Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology. | 2019 | Details |
| A09789 | 31610081 | Liver Transpl | Nonalcoholic Steatohepatitis After Liver Transplantation. | 2019 | Details |
| A09821 | 31598192 | World J Hepatol | Cirrhotic patients and older people. | 2019 | Details |
| A09829 | 31597010 | Liver Transpl | Increased Frequency of Heterozygous Alpha-1-Antitrypsin Deficiency in Liver Explants From Nonalcoholic Steatohepatitis Patients. | 2019 | Details |
| A09869 | 31582326 | Dig Liver Dis | Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinoma. | 2019 | Details |
| A09889 | 31574071 | Gastroenterol Nurs | Nonalcoholic Fatty Liver Disease: A Silent Epidemic. | 2020 | Details |
| A09894 | 31571145 | Arch Pharm Res | Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease. | 2019 | Details |
| A09948 | 31548169 | Ann Hepatol | Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review. | 2019 | Details |